甲状腺癌治疗后甲状旁腺功能减退患者的生活质量
HPT组在15个量表中有9个评分显著降低,回归分析显示HPT与多个QLQ-C30量表独立负相关,两组HPT典型症状发生率均较高。
要点
- 甲状腺癌术后HPT患者生活质量在多维度显著受损。
- HPT是多个生活质量量表评分的独立负性影响因素。
- 评估甲状腺癌患者生活质量时应同步评估HPT。
核心结论
- 甲状腺癌术后合并HPT的患者较无HPT者报告显著更差的生活质量。
- 在评估甲状腺癌患者生活质量时应考虑评估HPT。
研究设计与样本
- 分析人群来自一项在13个国家试点甲状腺癌特异性生活质量工具的研究。
- 生活质量采用EORTC QLQ-C30及部分HPT症状条目测量,HPT状态与临床数据来自病历。
- 组间QLQ-C30领域比较用Mann-Whitney U检验,HPT相关症状发生率比较用卡方检验,并有多重有序回归分析。
主要发现
- HPT组在EORTC QLQ-C30的15个量表中有9个报告生活质量显著降低。
- 回归分析显示HPT与多个QLQ-C30量表独立负相关。
- 两组均显示HPT典型症状的高发生率。
临床怎么用
- 对甲状腺癌术后患者进行生活质量评估时,应同步评估HPT状态。
- 关注HPT相关症状(如手指或脚趾刺痛)对生活质量的影响。
局限性
- HPT状态来自病历提取,非前瞻性统一判定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Surgical complications such as hypoparathyroidism (HPT) or vocal cord palsy are seldom assessed when the quality of life (QOL) in thyroid cancer patients is investigated. The aim of this study was to measure the QOL difference in thyroid cancer survivors with and without HPT. METHODS: Participants for this analysis were enrolled in 13 countries from a study that pilot-tested a thyroid cancer-specific QOL instrument. They were included if they had been diagnosed with thyroid cancer at least 9 months previously. QOL was measured using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core (EORTC QLQ-C30) and some items on HPT symptoms (eg, tingling in fingers or toes). HPT status and other clinical data were extracted from the patients' medical charts. Comparisons of QOL domains between patients with and without HPT were performed using Mann-Whitney U test. The occurrence of HPT-related symptoms was compared using chi-square tests. Multiple ordinal regression analysis was performed to evaluate factors that might affect QOL. RESULTS: Eighty-nine patients participated in this study, 17 of whom were considered to have HPT. Patients in the HPT group reported significantly reduced QOL in 9 of the 15 scales of the EORTC QLQ-C30 compared to patients without HPT. Regression analysis showed that HPT was independently negatively associated with various scales of the QLQ-C30. Both groups showed a high prevalence of typical HPT symptoms. CONCLUSION: Thyroid cancer patients with HPT report significantly impaired QOL compared to thyroid cancer survivors without HPT. The assessment of HPT should be considered when measuring QOL in thyroid cancer patients.
引用
- Büttner M, Locati LD, Pinto M, et al. Quality of Life in Patients With Hypoparathyroidism After Treatment for Thyroid Cancer. J Clin Endocrinol Metab. 2020. PMID: 32918085. doi:10.1210/clinem/dgaa597
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。